ConCallIQ
Go Pro

Gujarat Fluorochemicals FY25 Annual Earnings Summary

4 quarters covered · ₹4,737 Cr revenue · ₹546 Cr PAT · 24.5% average EBITDA margin.

Total annual revenue: ₹4,737 Cr
Annual PAT: ₹546 Cr
Average margin: 24.5%
Promise delivery: 0%

Quarter-by-quarter progression

QuarterRevenuePATMarginSentiment
Q1 FY25₹1,176 Cr₹108 Cr22.0%neutral
Q2 FY25₹1,188 Cr₹121 Cr25.0%bullish
Q3 FY25₹1,148 Cr₹126 Cr26.0%bullish
Q4 FY25₹1,225 Cr₹191 Cr25.0%bullish

Management promises made during the year

CapEx of INR 800 crore for battery chemicals in FY25

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q1 FY25
missed
Fluoropolymer segment to see continuous growth in FY25

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q1 FY25
missed
LFP plant commissioning in Q3 FY25

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q2 FY25
missed
Commercial supplies from EV business to commence from Q4 FY25

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q3 FY25
missed
Substantial improvement in financials from Q4 FY25 onwards

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q3 FY25
missed

Risks flagged during the year

Q1 FY25 · high

Validation and approval cycles for EV battery materials are long, leading to a lag in revenue generation despite high CapEx.

Q2 FY25 · high

Battery materials qualification and commercial agreements may take longer than anticipated, delaying revenue and profitability from the EV segment.

Q1 FY25 · medium

Analyst raised concern about Chinese capacity additions pressuring pricing; management downplayed impact by focusing on high-value segments.

Q1 FY25 · medium

Shipping delays via Cape of Good Hope caused ~INR 70-80 crore revenue deferment in Q1; may persist.

Q2 FY25 · medium

Overcapacity in China continues to pressure pricing in bulk chemicals and fluorochemicals, potentially delaying margin recovery.

Q2 FY25 · medium

Despite expectations, the redistribution of volumes from the exiting legacy player may not result in a proportional market share gain for GFL due to competition from other players.

Q3 FY25 · medium

The decision to invest in R32 capacity is based on current pricing and demand-supply dynamics; a reversal in pricing could affect the viability of the investment.

Q3 FY25 · medium

Changes in US policy, such as revocation of IRA subsidies, could impact the EV battery materials business, though management believes customer plans remain intact.

Q3 FY25 · medium

The electrolyte business for the domestic market is experiencing hiccups as customers' plants face startup delays, which could slow revenue contributions.

Q3 FY25 · medium

Commodity-grade PTFE continues to face pricing pressure from low-cost Chinese suppliers, and additional MDC capacity in India could keep prices muted.

Q4 FY25 · medium

Revenue from EV battery materials may be delayed if customer qualifications or market ramp-up take longer than expected.

Q4 FY25 · medium

The CMS-1 plant incident caused ~15% production loss, and MDC price declines may persist, impacting profitability.

What changed through the year

G

Q1 FY25 · EBITDA run-rate target of INR 1,700-1,800 crore

Management expects to reach the FY23 EBITDA run-rate by Q4 FY25, give or take a quarter.

G

Q1 FY25 · Commercial supplies of battery materials from Q4 FY25

LiPF6, electrolyte, and PVDF binder commercial supplies expected to commence from Q4 FY2025.

G

Q1 FY25 · LFP plant commissioning in Q3 FY25

The LFP plant is expected to be commissioned in the third quarter of this financial year.

G

Q1 FY25 · New fluoropolymer capacity utilization by Q4 FY25

Management expects to substantially utilize new fluoropolymer capacities by Q4 FY25.

G

Q2 FY25 · EV business: 2x asset turnover and 25% EBITDA margins at optimal utilization

Management reiterated guidance for GFCL EV to achieve 2x asset turnover and 25% EBITDA margins once capacities reach optimal utilization levels.

G

Q2 FY25 · Cumulative CapEx of INR 5,000 crore by FY27 and INR 6,000 crore by FY28 for EV

The company plans to invest INR 5,000 crore by FY27 and INR 6,000 crore by FY28 in the battery materials business, funded through equity and internal accruals.

G

Q2 FY25 · Commercial supplies from EV business to commence from Q4 FY25

Management expects initial commercial supplies of battery materials (salt, electrolyte, etc.) to start from Q4 FY25, following customer qualifications.

G

Q2 FY25 · Substantial improvement in financials from Q4 FY25 onwards

Driven by fluoropolymer growth, refrigerant price recovery, and EV ramp-up, management expects a significant improvement in overall performance from Q4 FY25.

G

Q3 FY25 · Fluoropolymer full capacity utilization by end-FY26

Management expects to achieve full capacity utilization in the fluoropolymer segment by the end of FY26, driven by new product qualifications and market demand.

G

Q3 FY25 · R32 capacity of 30,000 tons with first phase of 20,000 tons by Q4 FY26

GFL plans to set up 30,000 tons of R32 capacity in phases, with the first phase of 20,000 tons expected to be operational by Q4 FY26, at a CapEx of around INR 150 crores.

G

Q3 FY25 · EV battery materials cumulative CapEx of INR 6,000 crores by FY28

GFL remains committed to its cumulative CapEx plan of INR 6,000 crores by FY28 for the EV battery materials business, targeting ~2x asset turnover and ~25% EBITDA margins at optimal utilization.

G

Q3 FY25 · Power cost savings of ~INR 150 crores annually from FY26

Through renewable energy PPAs, GFL expects annual power cost savings of approximately INR 150 crores, reducing the weighted average power cost to around INR 4.5 per unit.

G

Q4 FY25 · Fluoropolymer growth of ~25% in FY26

Management expects ~25% year-on-year growth in fluoropolymers revenue, driven by new fluoropolymers and legacy player exits.

G

Q4 FY25 · R32 commissioning in H2 FY26

R32 plant expected to commence commercial sales in the second half of FY26, with a target capacity of 20,000 tonnes.

G

Q4 FY25 · EV battery revenue trickling in from H2 FY26

Revenue from EV battery materials (LiPF6, LFP, binders, electrolytes) expected to start in H2 FY26, with ramp-up in FY27.

G

Q4 FY25 · CapEx of INR 1,600 crore for FY26

Planned CapEx of INR 1,600 crore, with INR 1,200 crore for EV battery materials and INR 400 crore for fluoropolymers and refrigerants.